MedTrace Logo

Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study

NCT01485666 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-06-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate the feasibility of a Percutaneous Lead Management Kit for HeartMate II driveline stabilization and exit site management.

Conditions

  • Left Ventricular Assist Device
  • Percutaneous Lead Management

Interventions

OTHER

Percutaneous Lead Management Kit

A kit of commercially available components to be used for HeartMate II driveline exit site cleaning, dressing and stabilization

Sponsors & Collaborators

  • Thoratec Corporation

    collaborator INDUSTRY

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Pooja Chatterjee · Thoratec Corporation

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01485666 on ClinicalTrials.gov